Kong Yuan, Wang Yu-Tong, Cao Xie-Na, Song Yang, Chen Yu-Hong, Sun Yu-Qian, Wang Yu, Zhang Xiao-Hui, Xu Lan-Ping, Huang Xiao-Jun
Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, 100044, China.
Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, 100871, China.
J Transl Med. 2017 Mar 14;15(1):57. doi: 10.1186/s12967-017-1159-y.
Poor graft function (PGF) is a life-threatening complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Nevertheless, whether abnormalities of T cell subsets in the bone marrow (BM) immune microenvironment, including Th17, Tc17, Th1, Tc1, Th2, Tc2 cells and regulatory T cells (Tregs), are involved in the pathogenesis of PGF remains unclear.
This prospective nested case-control study enrolled 20 patients with PGF, 40 matched patients with good graft function (GGF) after allo-HSCT, and 20 healthy donors (HD). Th17, Tc17, Th1, Tc1, Th2, Tc2 cells, Tregs and their subsets were analyzed by flow cytometry.
A significantly higher proportion of stimulated CD4 and CD8 T cells that produced IL-17 (Th17 and Tc17) was found in the BM of PGF patients than in the BM of GGF patients and HD, whereas the percentages of Tregs in PGF patients were comparable to those in GGF patients and HD, resulting in a dramatically elevated ratio of Th17 cells/Tregs in the BM of PGF patients relative to those in GGF patients. Moreover, both CD4 and CD8 T cells were polarized towards a type 1 immune response in the BM of PGF patients.
The present study revealed that aberrant T cell responses in the BM immune microenvironment may be involved in the pathogenesis of PGF after allo-HSCT. These findings will facilitate the optimization of immune regulation strategies and improve the outcome of PGF patients post-allotransplant.
移植功能不良(PGF)是异基因造血干细胞移植(allo-HSCT)后一种危及生命的并发症。然而,骨髓(BM)免疫微环境中T细胞亚群异常,包括Th17、Tc17、Th1、Tc1、Th2、Tc2细胞和调节性T细胞(Tregs),是否参与PGF的发病机制仍不清楚。
这项前瞻性巢式病例对照研究纳入了20例PGF患者、40例allo-HSCT后移植功能良好(GGF)的匹配患者以及20名健康供者(HD)。通过流式细胞术分析Th17、Tc17、Th1、Tc1、Th2、Tc2细胞、Tregs及其亚群。
与GGF患者和HD的骨髓相比,PGF患者骨髓中产生白细胞介素-17的刺激CD4和CD8 T细胞(Th17和Tc17)比例显著更高,而PGF患者中Tregs的百分比与GGF患者和HD相当,导致PGF患者骨髓中Th17细胞/Tregs的比例相对于GGF患者显著升高。此外,PGF患者骨髓中的CD4和CD8 T细胞均向1型免疫反应极化。
本研究表明,BM免疫微环境中异常的T细胞反应可能参与allo-HSCT后PGF的发病机制。这些发现将有助于优化免疫调节策略,并改善PGF患者移植后的结局。